ACE and aortic stenosis: The HOCM patients were more likely to be on beta-blockers than the severe AS patients (69.4% versus 40.0%, p = 0.001) but were similar in terms of antithrombotic agents, statins (p = 0.983), angiotensin converting enzyme inhibitors (ACEis) and angiotensin receptor blockers (ARBs) (p = 0.382) (Table 1).